For patients with iliac artery blockages, treatment with a self-expanding stent provides better protection against restenosis at 12 months and no reduction in safety compared with a balloon-expandable ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Self-expanding and balloon-expandable stents were equally safe and effective in patients with iliac ...

Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who historically have been excluded from clinical trials—is safe and effective ...

Although the formation of collaterals is classically regarded as a compensatory mechanism to bypass and thus alleviate an obstruction, the mechanism and inducement of collateral formation are unknown.

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9r4nlm/medipoint) has announced the addition of the "MediPoint: Peripheral ...

BD’s Revello Vascular Covered Stent receives CE marking to treat atherosclerotic lesions in common and external iliac arteries: Franklin Lakes, New Jersey Monday, March 9, 2026, ...

EL PASO, Texas -- William Beaumont Army Medical Center became the first military treatment facility in the Department of Defense to use the first "off-the-shelf" aortic branch device (stent graft) ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a self-expanding peripheral stent system for use in the common iliac, external iliac, ...

BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.

The US Food and Drug Administration (FDA) has approved Abbott's Absolute Pro Vascular Self-Expanding Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...